Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spyre Therapeutics (SYRE) Receivables - Other: 2015-2022

Historic Receivables - Other for Spyre Therapeutics (SYRE) over the last 5 years, with Dec 2022 value amounting to $375,000.

  • Spyre Therapeutics' Receivables - Other was N/A to $163,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $163,000, marking a year-over-year change of. This contributed to the annual value of $375,000 for FY2022, which is 53.99% down from last year.
  • Latest data reveals that Spyre Therapeutics reported Receivables - Other of $375,000 as of FY2022, which was down 53.99% from $815,000 recorded in FY2021.
  • In the past 5 years, Spyre Therapeutics' Receivables - Other ranged from a high of $815,000 in FY2021 and a low of $375,000 during FY2022.
  • Moreover, its 2-year median value for Receivables - Other was $595,000 (2021), whereas its average is $595,000.
  • Data for Spyre Therapeutics' Receivables - Other shows a maximum YoY plummeted of 53.99% (in 2022) over the last 5 years.
  • Spyre Therapeutics' Receivables - Other (Yearly) stood at $815,000 in 2021, then slumped by 53.99% to $375,000 in 2022.